Related Experiment Video
Updated: Feb 14, 2026
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Aspirin and intracerebral hemorrhage: Where are we now?
1Division of Cerebrovascular Diseases & Neurocritical Care, Department of Neurology, The Ohio State University College of Medicine; and the Neurosciences Critical Care Unit, The Ohio State University Wexner Medical Center, Columbus.
Insights
Aspirin effectively prevents vascular events like stroke but its link to intracerebral hemorrhage risk remains debated. This review examines current and past data on aspirin use and brain hemorrhage.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Aspirin has been a cornerstone for preventing ischemic stroke and myocardial infarction for 30 years.
- Evidence for aspirin's efficacy in preventing vascular events is well-established.
- Conflicting data exists regarding aspirin's association with acute and recurrent intracerebral hemorrhage.
Purpose of the Study:
- To review and synthesize existing and current data on the relationship between aspirin use and intracerebral hemorrhage.
- To clarify the risks and benefits of aspirin concerning brain hemorrhage.
Main Methods:
- Comprehensive literature review of past and contemporary studies.
- Analysis of data on aspirin use and incidence of intracerebral hemorrhage.
- Evaluation of conflicting findings in existing research.
Main Results:
- Data on aspirin's role in intracerebral hemorrhage risk is inconsistent across studies.
- Further investigation is needed to reconcile conflicting findings.
- Understanding the precise risk-benefit profile is crucial.
Conclusions:
- The association between aspirin and intracerebral hemorrhage requires careful consideration.
- Clinical decisions regarding aspirin use should weigh its benefits against potential bleeding risks.
- Ongoing research is vital for definitive conclusions.
Abstract:
For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.
